When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...

3. Pegaptanib - Wikipedia

   en.wikipedia.org/wiki/Pegaptanib

   Pegaptanib [2] sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). [3] It was discovered by NeXstar Pharmaceuticals (which merged with Gilead Sciences in 1999) and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States.

4. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   Drug Manufacturer Indication Avacincaptad pegol: To treat geographic atrophy secondary to age-related macular degeneration [4] Cipaglucosidase alfa: To treat late-onset Pompe disease with miglustat [4] Dabrafenib: Dostarlimab: Eflornithine: Elranatamab: To treat relapsed or refractory multiple myeloma after at least four lines of therapy [4 ...

5. Aflibercept - Wikipedia

   en.wikipedia.org/wiki/Aflibercept

   In November 2011, the US Food and Drug Administration (FDA) approved aflibercept for the treatment of wet macular degeneration. [ 31 ] [ 32 ] In August 2012, the US FDA approved aflibercept (Zaltrap) for use in combination with 5-fluorouracil , folinic acid and irinotecan to treat adults with metastatic colorectal cancer that is resistant to ...

6. Regeneron Wins FDA Approval for Macular-Degeneration Drug - AOL

   www.aol.com/news/2011-11-19-regeneron-wins-fda...

   The folks at Regeneron Pharmaceuticals (NAS: REGN) are going to have a happy weekend right before they settle down for Thanksgiving. Tarrytown, N.Y.-based Regeneron said yesterday it has gotten ...

7. US FDA approves higher dose of Regeneron's eye disease ... - AOL

   www.aol.com/news/us-fda-approves-higher-dose...

   The drug, Eylea HD, is priced at $2,625 per single-use vial in the U.S. and is used to treat patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME) and diabetic ...